BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29432652)

  • 1. Osteonecrosis of the jaws: a 14-year retrospective survey of hospital admissions.
    McGowan K; Ivanovski S; Acton C
    Aust Dent J; 2018 Jun; 63(2):202-207. PubMed ID: 29432652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonecrosis of the jaw and dental extractions: A single-center experience.
    Sandhu S; Salous MH; Sankar V; Margalit DN; Villa A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):515-521. PubMed ID: 32723683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan.
    Kunihara T; Tohmori H; Tsukamoto M; Kobayashi M; Okumura T; Teramoto H; Hamasaki T; Yamasaki T; Nakagawa T; Okimoto N; Fujiwara S
    Osteoporos Int; 2023 Jun; 34(6):1101-1109. PubMed ID: 37002373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
    Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians.
    Hong SO; Lee CY; Jung J; Kim DY; Walter C; Kwon YD
    Clin Oral Investig; 2017 Jun; 21(5):1905-1911. PubMed ID: 27771829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
    J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw.
    Akashi M; Wanifuchi S; Iwata E; Takeda D; Kusumoto J; Furudoi S; Komori T
    Oral Maxillofac Surg; 2018 Mar; 22(1):59-63. PubMed ID: 29224060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.
    Anastasilakis AD; Pepe J; Napoli N; Palermo A; Magopoulos C; Khan AA; Zillikens MC; Body JJ
    J Clin Endocrinol Metab; 2022 Apr; 107(5):1441-1460. PubMed ID: 34922381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Wehrhan F; Gross C; Creutzburg K; Amann K; Ries J; Kesting M; Geppert CI; Weber M
    J Transl Med; 2019 Mar; 17(1):69. PubMed ID: 30832685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort.
    Abel Mahedi Mohamed H; Nielsen CEN; Schiodt M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Feb; 125(2):157-163. PubMed ID: 29221983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which symptoms negatively affect the oral health-related quality of life in patients with osteonecrosis of the jaw?
    Sato T; Kusumoto J; Takeda D; Kishimoto M; Kashin M; Furudoi S; Akashi M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug; 130(2):175-180. PubMed ID: 32493679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
    Kün-Darbois JD; Fauvel F
    Morphologie; 2021 Jun; 105(349):170-187. PubMed ID: 33281055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaws in patients under osteoporosis treatment: a nine-year experience report.
    Penoni DC; Canellas JVS; Silami MANC; Sader F; Pimentel GS; Leão ATT
    Arch Endocrinol Metab; 2023 May; 67(4):e000612. PubMed ID: 37252700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoradionecrosis and medication-related osteonecrosis of the jaw: similarities and differences.
    Grisar K; Schol M; Schoenaers J; Dormaar T; Coropciuc R; Vander Poorten V; Politis C
    Int J Oral Maxillofac Surg; 2016 Dec; 45(12):1592-1599. PubMed ID: 27427547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of clindamycin concentrations in human plasma and jawbone tissue in patients with osteonecrosis of the jaw: A prospective trial.
    Straub A; Stapf M; Brands RC; Kübler AC; Lâm TT; Vollmer A; Gubik S; Scherf-Clavel O; Hartmann S
    J Craniomaxillofac Surg; 2024 Mar; 52(3):355-362. PubMed ID: 38368214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jaw.
    Schwaneck EC; Streit A; Krone M; Hartmann S; Müller-Richter U; Kübler AC; Gadeholt O; Schmalzing M; Tony HP; Brands RC
    Z Rheumatol; 2020 Mar; 79(2):203-209. PubMed ID: 30796524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of jaw osteonecrosis diagnostic criteria in cancer patients with a history of radiation therapy and exposure to bone-modifying agents.
    Zadik Y; Ganor Y; Rimon O; Bersudski E; Meirovitz A
    Radiother Oncol; 2021 Mar; 156():275-280. PubMed ID: 33373641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.
    Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun; 131(6):650-659. PubMed ID: 33518491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.